Non-statin lipid-lowering therapy over time in very-high-risk patients: effectiveness of fixed-dose statin/ezetimibe compared to separate pill combination on LDL-C

BACKGROUND: Many patients at very-high atherosclerotic cardiovascular disease risk do not reach guideline-recommended targets for LDL-C. There is a lack of data on real-world use of non-statin lipid-lowering therapies (LLT) and little is known on the effectiveness of fixed-dose combinations (FDC). W...

Descripción completa

Detalles Bibliográficos
Autores principales: Katzmann, Julius L., Sorio-Vilela, Francesc, Dornstauder, Eugen, Fraas, Uwe, Smieszek, Timo, Zappacosta, Sofia, Laufs, Ulrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873069/
https://www.ncbi.nlm.nih.gov/pubmed/32949286
http://dx.doi.org/10.1007/s00392-020-01740-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873069/
https://www.ncbi.nlm.nih.gov/pubmed/32949286
http://dx.doi.org/10.1007/s00392-020-01740-8

Ejemplares similares